NovaBay Pharmaceuticals, Inc. 4
4 · NovaBay Pharmaceuticals, Inc. · Filed Oct 6, 2015
Insider Transaction Report
Form 4
Stroman David W.
SVP, Ophthalmic Product Devt.
Transactions
- Award
Option (right to buy)
2015-10-05+100,000→ 474,834 totalExercise: $0.27From: 2016-10-05Exp: 2025-10-05→ common stock (100,000 underlying)
Footnotes (1)
- [F1]Options granted pursuant to the 2007 Omnibus Incentive Plan and NovaBay's Annual Employee Equity Refresh Program. 25% will vest on the first anniversary of the Grant Date. 6.25% will vest every three months thereafter.